학술논문

The proneural subtype is not associated with survival benefit from bevacizumab in newly diagnosed glioblastoma: a secondary analysis of the GLARIUS trial
Document Type
Article
Source
In: Journal of Neuro-Oncology. (Journal of Neuro-Oncology, September 2023, 164(3):749-755)
Subject
Language
English
ISSN
15737373
0167594X